OR WAIT null SECS
Our best read stories about formularies include news about 2022 formularies from CVS Caremark and Express Scripts.
Four products on the preferred list this year will be excluded next year.
The COX-2 inhibitor Anjeso, a faster-acting injectable formulation of meloxicam, reduces opioid use after surgery.
CVS Caremark has removed 10 branded products from its formulary and added about 30 additional products.
Cigna plans to remove 45 drugs from its Standard Prescription Drug List and add restrictions for other therapeutics.
Prime’s formularies will include the insulin biosimilar over the reference product Lantus beginning in January 2022.